Dror Bashan joined Protalix Biotherapeutics as President and Chief Executive Officer, and as a Director of the Company, in June 2019. He has over 20 years of experience in the pharmaceutical industry with roles ranging from business development, marketing, sales and finance providing him with both cross-regional and cross-discipline experience and a deep knowledge of the global pharmaceutical and health industries. Mr. Bashan holds a BA in economics and business management from the Tel Aviv University and an MBA from the Tel Aviv University.
.svg)
